v3.24.3
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Revenue:        
Total revenue $ 90,377 $ 47,725 $ 237,474 $ 116,820
Operating expenses:        
Cost of sales 20,806 10,228 58,863 22,019
Research and development 31,710 26,117 96,604 71,674
Selling, general and administrative 50,545 36,528 145,391 99,696
Total operating expenses 103,061 72,873 300,858 193,389
Loss from operations (12,684) (25,148) (63,384) (76,569)
Other income (expense):        
Interest income 3,469 4,061 10,588 9,960
Interest expense (3,586) (3,574) (10,732) (11,542)
Loss from termination of revenue interest purchase agreement 0 0 0 (49,076)
Other income (expense), net (1,087) 1,322 982 237
Net loss before provision for income taxes (13,888) (23,339) (62,546) (126,990)
Provision for income taxes 347 249 1,606 766
Net loss $ (14,235) $ (23,588) $ (64,152) $ (127,756)
Net loss per share, basic (in dollars per share) $ (0.30) $ (0.57) $ (1.36) $ (3.28)
Net loss per share, diluted (in dollars per share) $ (0.30) $ (0.57) $ (1.36) $ (3.28)
Weighted-average shares of common stock outstanding, basic (in shares) 47,782,619 41,098,920 47,316,789 38,973,060
Weighted-average shares of common stock outstanding, diluted (in shares) 47,782,619 41,098,920 47,316,789 38,973,060
Product sales, net        
Revenue:        
Total revenue $ 90,302 $ 47,725 $ 236,979 $ 109,320
License and other revenue        
Revenue:        
Total revenue $ 75 $ 0 $ 495 $ 7,500